{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T01:01:08Z","timestamp":1794013268111,"version":"4.8.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T00:00:00Z","timestamp":1668038400000},"content-version":"vor","delay-in-days":9,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100016281","name":"Sharda University","doi-asserted-by":"publisher","award":["5\/8\/3(11)\/2009-ECD-I(A)"],"award-info":[{"award-number":["5\/8\/3(11)\/2009-ECD-I(A)"]}],"id":[{"id":"10.13039\/501100016281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.heliyon.2022.e11633","type":"journal-article","created":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T21:00:42Z","timestamp":1668459642000},"page":"e11633","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Activated TLR2\/4-positive T cells boost cell exhaustion during lepromatous leprosy infection via PD-1 upregulation"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1133-9830","authenticated-orcid":false,"given":"Soumi","family":"Sadhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6296-0291","authenticated-orcid":false,"given":"Sanjay","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipendra Kumar","family":"Mitra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beenu","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2022.e11633_bib1","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1590\/0074-02760160490","article-title":"Towards leprosy elimination by 2020: forecasts of epidemiological indicators of leprosy in Corrientes, a province of northeastern Argentina that is a pioneer in leprosy elimination","volume":"112","author":"de Odriozola","year":"2017","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.heliyon.2022.e11633_bib2","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.clindermatol.2015.11.001","article-title":"Epidemiologic trends of leprosy for the 21st century","volume":"34","author":"Schreuder","year":"2016","journal-title":"Clin. Dermatol."},{"key":"10.1016\/j.heliyon.2022.e11633_bib3","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.clim.2011.06.007","article-title":"Th3 Immune responses in the progression of leprosy via molecular cross-talks of TGF-\u03b2, CTLA-4 and Cbl-b","volume":"141","author":"Kumar","year":"2011","journal-title":"Clin. Immunol."},{"issue":"5","key":"10.1016\/j.heliyon.2022.e11633_bib4","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1007\/s10067-022-06090-6","article-title":"Neglected tropical rheumatic diseases","volume":"41","author":"Wakhlu","year":"2022","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.heliyon.2022.e11633_bib5","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.clim.2011.08.007","article-title":"A\u00a0network of regulatory pathways in lepromatous leprosy","volume":"141","author":"Abbas","year":"2011","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.heliyon.2022.e11633_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004345","article-title":"Pauci- and multibacillary leprosy: two distinct, genetically neglected diseases","volume":"10","author":"Gaschignard","year":"2016","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.heliyon.2022.e11633_bib7","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.intimp.2018.03.002","article-title":"Toll-like receptors in immunity and inflammatory diseases: past, present, and future","volume":"59","author":"Vijay","year":"2018","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.heliyon.2022.e11633_bib8","doi-asserted-by":"crossref","first-page":"223","DOI":"10.4103\/ijd.IJD_486_17","article-title":"Toll-like receptors in dermatology, venereology, and leprosy","volume":"66","author":"Gandhi","year":"2021","journal-title":"Indian J. Dermatol."},{"key":"10.1016\/j.heliyon.2022.e11633_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000979","article-title":"Leprosy and the adaptation of human toll-like receptor 1","volume":"6","author":"Wong","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.heliyon.2022.e11633_bib10","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nm864","article-title":"Activation and regulation of Toll-like receptors 2 and 1 in human leprosy","volume":"9","author":"Krutzik","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.heliyon.2022.e11633_bib11","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/imr.12960","article-title":"Susceptibility and resistance in leprosy: studies in the mouse model","volume":"301","author":"Adams","year":"2021","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.heliyon.2022.e11633_bib12","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.3389\/fimmu.2017.01635","article-title":"Leprosy as a complex infection: breakdown of the Th1 and Th2 immune paradigm in the immunopathogenesis of the disease","volume":"8","author":"de Sousa","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2022.e11633_bib13","doi-asserted-by":"crossref","first-page":"P190","DOI":"10.1186\/1742-4690-7-S1-P190","article-title":"Serum levels of inflammatory cytokines in leprosy patients","volume":"7","author":"de Paula","year":"2010","journal-title":"Retrovirology"},{"key":"10.1016\/j.heliyon.2022.e11633_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079072","article-title":"Increased frequency of CD4 and CD8 regulatory T cells in individuals under 15 years with multibacillary leprosy","volume":"8","author":"Fernandes","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2022.e11633_bib15","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/84620","article-title":"T-cell release of granulysin contributes to host defense in leprosy","volume":"7","author":"Ochoa","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.heliyon.2022.e11633_bib16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-2133.2012.10891.x","article-title":"The effect of systemic corticosteroid therapy on the expression of toll-like receptor 2 and toll-like receptor 4 in the cutaneous lesions of leprosy Type 1 reactions","volume":"167","author":"Walker","year":"2012","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.heliyon.2022.e11633_bib17","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s10096-009-0746-0","article-title":"Polymorphisms in Toll-like receptor 4 (TLR4) are associated with protection against leprosy","volume":"28","author":"Bochud","year":"2009","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.heliyon.2022.e11633_bib18","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/3405103","article-title":"Differential expression of IFN-\u03b3, IL-10, TLR1, and TLR2 and their potential effects on downgrading leprosy reaction and erythema nodosum leprosum","author":"Antunes","year":"2019","journal-title":"J.\u00a0Immunol. Res"},{"key":"10.1016\/j.heliyon.2022.e11633_bib19","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.imlet.2017.02.013","article-title":"T\u00a0helper cells in leprosy: an update","volume":"184","author":"Saini","year":"2017","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.heliyon.2022.e11633_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108515","article-title":"The IL-2 - IL-2 receptor pathway in health and disease: the role of the soluble IL-2 receptor","volume":"218","author":"Damoiseaux","year":"2020","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.heliyon.2022.e11633_bib21","article-title":"PD-1\/PD-L1 checkpoint inhibitors in tumor immunotherapy","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.heliyon.2022.e11633_bib22","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.it.2006.02.001","article-title":"The PD-1-PD-L pathway in immunological tolerance","volume":"27","author":"Okazaki","year":"2006","journal-title":"Trends Immunol."},{"key":"10.1016\/j.heliyon.2022.e11633_bib23","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2217\/imt-2017-0120","article-title":"PD-1\/PD-L1 in disease","volume":"10","author":"Kuol","year":"2018","journal-title":"Immunotherapy"},{"key":"10.1016\/j.heliyon.2022.e11633_bib24","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1084\/jem.20090847","article-title":"PD-L1 regulates the development, maintenance, and function of induced regulatory T cells","volume":"206","author":"Francisco","year":"2009","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.heliyon.2022.e11633_bib25","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.immuni.2016.04.020","article-title":"CD28 costimulation: from mechanism to therapy","volume":"44","author":"Esensten","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.heliyon.2022.e11633_bib26","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/1521-4141(200203)32:3<634::AID-IMMU634>3.0.CO;2-9","article-title":"PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2","volume":"32","author":"Carter","year":"2002","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.heliyon.2022.e11633_bib27","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/s41598-018-36403-2","article-title":"PD-1\/PD-L1 pathway modulates macrophage susceptibility to Mycobacterium tuberculosis specific CD8+ T cell induced death","volume":"9","author":"Suarez","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.heliyon.2022.e11633_bib28","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3389\/fimmu.2020.00487","article-title":"The role of PD-1 in acute and chronic infection","volume":"11","author":"Jubel","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2022.e11633_bib29","first-page":"451","article-title":"Histological classification and the immunological spectrum of leprosy","volume":"51","author":"Ridley","year":"1974","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.heliyon.2022.e11633_bib30","first-page":"255","article-title":"Classification of leprosy according to immunity. A five-group system","volume":"34","author":"Ridley","year":"1966","journal-title":"Int. J. Lepr. Other Mycobact. Dis."},{"key":"10.1016\/j.heliyon.2022.e11633_bib31","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.smim.2010.01.002","article-title":"The role of invariant NKT cells at the interface of innate and adaptive immunity","volume":"22","author":"Cerundolo","year":"2010","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.heliyon.2022.e11633_bib32","doi-asserted-by":"crossref","first-page":"116","DOI":"10.4049\/jimmunol.181.1.116","article-title":"Programmed death (PD)-1:PD-ligand 1\/PD-ligand 2 pathway inhibits T cell effector functions during human tuberculosis","volume":"181","author":"Jurado","year":"2008","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.heliyon.2022.e11633_bib33","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.3389\/fimmu.2019.01906","article-title":"CD8+ T lymphocyte and NK cell network: circuitry in the cytotoxic domain of immunity","volume":"10","author":"Uzhachenko","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2022.e11633_bib34","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/QAD.0b013e3282f4de23","article-title":"Up-regulation of PD-L1 on monocytes and dendritic cells by HIV-1 derived TLR ligands","volume":"22","author":"Meier","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.heliyon.2022.e11633_bib35","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/1523-1747.ep12381958","article-title":"Th1-Th2 paradigm: insights from leprosy","volume":"102","author":"Modlin","year":"1994","journal-title":"J.\u00a0Invest. Dermatol."},{"key":"10.1016\/j.heliyon.2022.e11633_bib36","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1489\/1544-581X(2005)73[25:LRDBMO]2.0.CO;2","article-title":"Leprosy research declines, but most of the basic questions remain unanswered","volume":"73","author":"Scollard","year":"2005","journal-title":"Int. J. Lepr. Other Mycobact. Dis."},{"key":"10.1016\/j.heliyon.2022.e11633_bib37","first-page":"19","article-title":"Sustained T-cell reactivity to Mycobacterium tuberculosis specific antigens in \u201csplit-anergic\u201d leprosy","volume":"66","author":"Kaleab","year":"1995","journal-title":"Lepr. Rev."},{"key":"10.1016\/j.heliyon.2022.e11633_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2021.108875","article-title":"Macrophages in tumor: an inflammatory perspective","volume":"232","author":"Goswami","year":"2021","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.heliyon.2022.e11633_bib39","first-page":"2383","article-title":"The TLR and IL-1 signalling network at a glance","volume":"127","author":"Cohen","year":"2014","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.heliyon.2022.e11633_bib40","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3390\/biology11020246","article-title":"The role of TLR2 in infectious diseases caused by mycobacteria: from cell biology to therapeutic target","volume":"11","author":"Hu","year":"2022","journal-title":"Biology"},{"key":"10.1016\/j.heliyon.2022.e11633_bib41","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.cellimm.2009.10.007","article-title":"Role of TLR2- and TLR4-mediated signaling in Mycobacterium tuberculosis-induced macrophage death","volume":"260","author":"S\u00e1nchez","year":"2010","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.heliyon.2022.e11633_bib42","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3389\/fcimb.2016.00072","article-title":"Mycobacterium leprae activates toll-like receptor-4 signaling and expression on macrophages depending on previous Bacillus calmette-guerin vaccination","volume":"6","author":"Polycarpou","year":"2016","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.heliyon.2022.e11633_bib43","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.bjid.2015.10.011","article-title":"TLR2 and TLR4 mediated host immune responses in major infectious diseases: a review","volume":"20","author":"Mukherjee","year":"2016","journal-title":"Braz. J. Infect. Dis."},{"key":"10.1016\/j.heliyon.2022.e11633_bib44","first-page":"1","article-title":"Genetic diversity of toll-like receptors and immunity to M. leprae infection","author":"Hart","year":"2012","journal-title":"J.\u00a0Trop. Med."},{"key":"10.1016\/j.heliyon.2022.e11633_bib45","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11904-011-0106-4","article-title":"Role of PD-1 in HIV pathogenesis and as target for therapy","volume":"9","author":"Porichis","year":"2012","journal-title":"Curr. HIV AIDS Rep."},{"key":"10.1016\/j.heliyon.2022.e11633_bib46","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1182\/blood.V128.22.929.929","article-title":"Correlation of toll-like receptor (TLR) and PD-1 pathways in central nervous system lymphoma: a clinicopathological study on outcomes","volume":"128","author":"Sethi","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.heliyon.2022.e11633_bib47","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.2147\/CMAR.S203156","article-title":"TLR4 expression correlated with PD-L1 expression indicates a poor prognosis in patients with peripheral T-cell lymphomas","volume":"11","author":"Zhao","year":"2019","journal-title":"Cancer Manag. Res."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844022029218?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844022029218?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:01:21Z","timestamp":1775606481000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844022029218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":47,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S2405844022029218"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2022.e11633","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activated TLR2\/4-positive T cells boost cell exhaustion during lepromatous leprosy infection via PD-1 upregulation","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2022.e11633","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e11633"}}